Alexandra K. Kiemer studied Pharmacy at the University of Munich (1989-1994) and obtained her PhD at the Institute of Pharmacology, Toxicology and Pharmacy of the Veterinary School at the same University (1995-1997). In 1998, she began a joint post-doc position at the Department of Medicine II and at the Centre of Drug Research, Department of Pharmacy, Pharmaceutical Biology, both at the University of Munich. After being awarded the Bavarian Habilitations Award, Dr. Kiemer worked at Kyowa Hakko Kogyo Ltd. (Tokyo, Japan), at the Department of Internal Medicine of the University of Florence (Italy), at the Australian Key Centre for Microscopy and Microanalysis of the University of Sydney (Australia) and at the Department of Immunology of The Scripps Research Institute – TSRI (La Jolla, USA). After her Habilitation in Pharmaceutical Biology and Pharmacology in 2003 at the University of Munich, she moved to the Department of Molecular and Experimental Medicine at TRSI. In 2004, she also joined the Department of Allergy and Immunology at the Medical School of the University of California San Diego (UCSD, La Jolla). She declined an offer from the Medical School at the Technical University of Dresden for an associate professorship in Pharmacology and Toxicology in 2004, and took up her present position as head of the Pharmaceutical Biology group at Saarland University in 2005.